OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Oncology Report

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2015.3792PMID 25673160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two Functional Forms of ACRBP/sp32 Are Produced by Pre-mRNA Alternative Splicing in the Mouse1

  2013cited by this paper
• Effect of shRNA-mediated inhibition of Nanog gene expression on the behavior of human gastric cancer cells

  2013cited by this paper
• NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.

  2013cited by this paper
• miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.

  2013cited by this paper
• miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2.

  2013cited by this paper
• HoxB3 promotes prostate cancer cell progression by transactivating CDCA3.

  2013cited by this paper
• Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.

  2013cited by this paper
• Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma

  2013cited by this paper
• Pfam: the protein families database

  2013cited by this paper
• Construction of Network for Protein Kinases That Play a Role in Acute Pancreatitis

  2013cited by this paper
• Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers

  2013cited by this paper
• Decreased CD27 on B Lymphocytes in Patients with Primary Hepatocellular Carcinoma

  2012cited by this paper
• Nanog regulates self‐renewal of cancer stem cells through the insulin‐like growth factor pathway in human hepatocellular carcinoma

  2012cited by this paper
• Knockdown of OY‐TES‐1 by RNAi causes cell cycle arrest and migration decrease in bone marrow‐derived mesenchymal stem cells

  2012cited by this paper
• F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.

  2012cited by this paper
• Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma.

  2012cited by this paper
• Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest

  2012cited by this paper
• Increased Nanog Expression Promotes Tumor Development and Cisplatin Resistance in Human Esophageal Cancer Cells

  2012cited by this paper
• A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.

  2012cited by this paper
• Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer

  2012cited by this paper
• Leukemogenesis as a new approach to investigate the correlation between up regulated gene 4/upregulator of cell proliferation (URG4/URGCP) and signal transduction genes in leukemia

  2012cited by this paper
• Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit

  2012cited by this paper
• Tetraspanin CD9 in cell migration.

  2011cited by this paper
• The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases

  2011influential reference
• Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma

  2011cited by this paper
• The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells.

  2011cited by this paper
• Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer.

  2011cited by this paper
• miR-497 and miR-302b Regulate Ethanol-induced Neuronal Cell Death through BCL2 Protein and Cyclin D2*

  2011cited by this paper
• Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.

  2010cited by this paper
• Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines

  2010cited by this paper
• DOMINE: a comprehensive collection of known and predicted domain-domain interactions

  2010cited by this paper
• MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2

  2010cited by this paper
• Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.

  2010cited by this paper
• The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function

  2010cited by this paper
• CCND2 polymorphisms associated with clearance of HBV Infection

  2010cited by this paper
• Expression of cancer/testis antigens in prostate cancer is associated with disease progression

  2010cited by this paper
• Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

  2010influential reference
• Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1.

  2010cited by this paper
• Inhibitor of Growth 4 Induces Growth Suppression and Apoptosis in Glioma U87MG

  2009influential reference
• Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer

  2009cited by this paper
• PTEN regulation by Akt–EGR1–ARF–PTEN axis

  2009cited by this paper
• OY-TES-1 expression and serum immunoreactivity in hepatocellular carcinoma

  2009cited by this paper
• Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587.

  2008cited by this paper
• The Pfam protein families database

  2007cited by this paper
• Induction of cytotoxic T cell response against HCA661 positive cancer cells through activation with novel HLA-A *0201 restricted epitopes.

  2007cited by this paper
• Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

  2007cited by this paper
• Network-based prediction of protein function

  2007cited by this paper
• Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis

  2007cited by this paper
• The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells

  2007cited by this paper
• OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.

  2006cited by this paper
• Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features

  2006cited by this paper
• Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells.

  2006cited by this paper
• ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.

  2006influential reference
• Identification of an HLA‐A24‐Restricted OY‐TES‐1 Epitope Recognized by Cytotoxic T‐Cells

  2005cited by this paper
• TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma

  2005cited by this paper
• Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues

  2005cited by this paper
• Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor.

  2005cited by this paper
• Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog

  2005cited by this paper
• Identification of a putative transactivation domain in human Nanog

  2005cited by this paper
• CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice.

  2005cited by this paper
• ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA‐damage agents in HepG2 cells

  2004influential reference
• CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells

  2004cited by this paper
• Expression of cancer-testis antigens in hepatocellular carcinoma.

  2004cited by this paper
• [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].

  2003cited by this paper
• Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer

  2003cited by this paper
• Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways

  2003influential reference
• A Key Role for the α1 Helix of Human RAP74 in the Initiation and Elongation of RNA Chains*

  2002cited by this paper
• CD27 and CD40 Inhibit p53-independent Mitochondrial Pathways in Apoptosis of B Cells Induced by B Cell Receptor Ligation*

  2002cited by this paper
• Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.

  2002cited by this paper
• A key role for the alpha 1 helix of human RAP74 in the initiation and elongation of RNA chains.

  2002cited by this paper
• Overexpression of tetraspanin CO-029 in hepatocellular carcinoma.

  2001cited by this paper
• Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen

  2001cited by this paper
• Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.

  2000cited by this paper
• An acrosomal protein, sp32, in mammalian sperm is a binding protein specific for two proacrosins and an acrosin intermediate.

  1994cited by this paper
• Identification of G1 kinase activity for cdk6, a novel cyclin D partner

  1994cited by this paper
• CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin.

  1994cited by this paper
• A region of antisense RNA from human p120 cDNA with high homology to mouse p120 cDNA inhibits NIH 3T3 proliferation.

  1992influential reference
• Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues.

  1987cited by this paper
• Secondary structure in the solution conformation of the proteinase inhibitor IIA from bull seminal plasma by nuclear magnetic resonance.

  1984cited by this paper

• Prognostic role of CDCA3 in lung adenocarcinoma with immune infiltration

  2026influential citation
• Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression.

  2024cites this paper
• Identification and Verification of Potential Ferroptosis-Related Biomarkers in Cervical Cancer

  2024cites this paper
• CDCA3 promotes the proliferation and migration of hypopharyngeal squamous cell carcinoma cells by activating the Akt/mTOR pathway

  2023cites this paper
• Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation

  2023cites this paper
• CDCA3 exhibits a role in promoting the progression of ovarian cancer.

  2022cites this paper
• Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

  2022cites this paper
• Potential prognostic value of hsa-miR-18a in hepatocellular carcinoma and the underlying key down-stream gene CHRM2: a comprehensive bioinformatic analysis*

  2021cites this paper
• CT23 knockdown attenuating malignant behaviors of hepatocellular carcinoma cell is associated with upregulation of metallothionein 1

  2021cites this paper
• The roles of the cell division cycle-associated gene family in hepatocellular carcinoma.

  2021cites this paper
• Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy

  2021cites this paper
• Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.

  2021cites this paper
• Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis

  2021cites this paper
• Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer

  2021cites this paper
• KIF22 promotes bladder cancer progression by activating the expression of CDCA3

  2021cites this paper
• Prognostic value of CDCA3 in kidney renal papillary cell carcinoma

  2021cites this paper
• Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy

  2021cites this paper
• The role of the CDCA gene family in ovarian cancer

  2020cites this paper
• Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients.

  2020cites this paper
• Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma

  2020cites this paper
• Analysis of the Expression of Cell Division Cycle-Associated Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases

  2020cites this paper
• Chitinase 3-Like 1, Nestin, and Testin Proteins as Novel Biomarkers of Potential Clinical Use in Colorectal Cancer: A Review.

  2020cites this paper
• CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer

  2018cites this paper
• Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient

  2018cites this paper
• Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer

  2017cites this paper
• Genome-wide targets identification of "core" pluripotency transcription factors with integrated features in human embryonic stem cells.

  2016cites this paper
• Curative Effect Research of Chinese medicine Combined with Minimally Invasive Non Vascular Interventional Therapy in the Treatment of Liver Malignant Tumor

  2016cites this paper
• Genetic analysis of radiation-specific biomarkers in sinonasal squamous cell carcinomas

  2016cites this paper
• Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.

  2015cites this paper